Auteurs : Philippe Beutels (Centre f
or Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Adriaan Blommaert (Centre f
or Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Germaine Hanquet (KCE), Joke Bilcke (Centre f
or Health Economics Research & Modelling Infectious Dis
...[+++]eases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Nancy Thiry (KCE), Martine Sabbe (Institut Scientifique de Santé Publique), Jan Verhaegen (Dept Microbiologie, UZ Leuven), Frank De Smet (Mutualité chrétienne), Michael Callens (Mutualité chrétienne), Pierre Van Damme (Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp).Auteurs: Philippe Beutels (Centre f
or Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Adriaan Blommaert (Centre f
or Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Germaine Hanquet (KCE), Joke Bilcke (Centre f
or Health Economics Research & Modelling Infectious Dise
...[+++]ases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Nancy Thiry (KCE), Martine Sabbe (Wetenschappelijk Instituut Volksgezondheid), Jan Verhaegen (Dept Microbiologie, UZ Leuven), Frank De Smet (Christelijke Mutualiteit), Michael Callens (Christelijke Mutualiteit), Pierre Van Damme (Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp).